COMMENT: 3.3 billion euro IMI2 to start in a month
Since its start six years ago, Europe's Innovative Medicines Initiative has firmly established itself as a key player in pharmaceutical research and innovation, and as a role model for collaborative research, open innovation and public-private
by Ruxandra Draghia-Akli
https://www.pharmatimes.com/news/comment_3.3_billion_euro_imi2_to_start_in_a_month_1002017